All In MedTech

FDA Clearance Tracker · K021204

OLYMPUS BF TYPE UM40

A 510(k) clearance means FDA found the device substantially equivalent to one already on the market. It is not an approval, and it is not a finding that the device works better than others.

Last checked: Nov 19, 2026Latest source record: May 1, 2002 (this decision)Source: openFDAMethods & limitations

510(k)First of its product codeThird-party review

Decided

May 1, 2002

Substantially Equivalent

Time to decision

15 days

Received Apr 16, 2002. Calendar days, including time FDA spent waiting on the applicant.

Pathway

510(k)

Traditional

Device class

Class II

The decision

FDA number
K021204
Device name
OLYMPUS BF TYPE UM40
Applicant location
Melville, NY
Received
Apr 16, 2002
Decided
May 1, 2002
Decision
Substantially Equivalent
Submission type
Traditional
Third-party review
Yes. An FDA-accredited third party reviewed this submission before FDA decided.

Device type

Device class
Class II
Regulation
21 CFR 892.1550

Every decision under product code PSV

How new is this?

These are facts about FDA's records. They are not a judgment about the device.

  • This is the earliest decision in FDA's data under product code PSV (Ultrasound Bronchoscope).
  • It is not on FDA's public list of Breakthrough Devices with marketing authorization (list dated June 30, 2026). FDA does not publish which devices hold the designation before they are authorized, and the list is updated only a few times a year.

Source documents

  • FDA database record for K021204
  • The applicant filed a summary instead of a public summary, or the summary is not at FDA's usual address. Check the FDA record.

The predicate devices this clearance relied on are named in the summary document. We do not extract them yet.

Other decisions for Olympus Optical Co., Ltd.

Matched on the applicant name as FDA recorded it. A company that files under several names will have more.

Company page

No other decisions since 2015 under this exact applicant name.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.